Table 2.
BRAF and RAS mutations in different TBSRTC categories [N = 80]
| TBSRTC | No. of | No mutation | Mutation | BRAF | NRAS | HRAS | KRAS |
|---|---|---|---|---|---|---|---|
| Category* | Cases | detected | detected | ||||
| Cat 3 | 18 | 9 | 9 (50%) | 1 | 6 | 1 | 1 |
| Cat 4 | 9 | 3 | 6 (66.7%) | 0 | 3 | 3 | 0 |
| Cat 5 | 16 | 9 | 7 (43.75%) | 3 | 4 | 0 | 0 |
| Cat 6 | 27 | 10 | 17 (66.7%) | 12 | 5 | 0 | 0 |
| Nodal metastases | 10 | 4 | 6 (55.6%) | 5 | 1 | 0 | 0 |
| Total | 80 | 35 | 45 (56.25%) | 21 | 19 | 4 | 1 |
| (46.7%) | (42.2%) | (8.9%) | (2.2%) |
*cases with technically noncontributory results excluded